| 000 | 01289 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517223021.0 | ||
| 264 | 0 | _c20190724 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2018.05.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnston, Tom H | |
| 245 | 0 | 0 |
_aRepurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c03 2019 |
||
| 300 |
_a11-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Repositioning |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aLacoste, Alix M B | |
| 700 | 1 | _aVisanji, Naomi P | |
| 700 | 1 | _aLang, Anthony E | |
| 700 | 1 | _aFox, Susan H | |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 773 | 0 |
_tNeuropharmacology _gvol. 147 _gp. 11-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2018.05.035 _zAvailable from publisher's website |
| 999 |
_c28535063 _d28535063 |
||